DiaMedica Therapeutics Inc (NASDAQ: DMAC) flaunted slowness of -14.10% at $5.42, as the Stock market unbolted on Thursday, before settling in for the price of $6.31 at the close. Taking a more long-term approach, DMAC posted a 52-week range of $3.19-$7.49.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 7.39%. Meanwhile, its Annual Earning per share during the time was 7.39%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -10.00%. This publicly-traded company’s shares outstanding now amounts to $52.08 million, simultaneously with a float of $24.39 million. The organization now has a market capitalization sitting at $280.16 million. At the time of writing, stock’s 50-day Moving Average stood at $6.78, while the 200-day Moving Average is $5.22.
DiaMedica Therapeutics Inc (DMAC) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the DiaMedica Therapeutics Inc industry. DiaMedica Therapeutics Inc’s current insider ownership accounts for 52.82%, in contrast to 17.55% institutional ownership. According to the most recent insider trade that took place on Aug 25 ’25, this organization’s 10% Owner bought 338,265 shares at the rate of 6.00, making the entire transaction reach 2,029,252 in total value, affecting insider ownership by 7,654,045. Preceding that transaction, on Aug 13 ’25, Company’s 10% Owner bought 293,601 for 5.91, making the whole transaction’s value amount to 1,734,918. This particular insider is now the holder of 7,058,066 in total.
DiaMedica Therapeutics Inc (DMAC) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year. DiaMedica Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -10.00% and is forecasted to reach -0.73 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -12.31% through the next 5 years, which can be compared against the 7.39% growth it accomplished over the previous five years trading on the market.
DiaMedica Therapeutics Inc (NASDAQ: DMAC) Trading Performance Indicators
Let’s observe the current performance indicators for DiaMedica Therapeutics Inc (DMAC). It’s Quick Ratio in the last reported quarter now stands at 10.67.
In the same vein, DMAC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.72, a figure that is expected to reach -0.17 in the next quarter, and analysts are predicting that it will be -0.73 at the market close of one year from today.
Technical Analysis of DiaMedica Therapeutics Inc (DMAC)
Now, what If we examine the latest scores posted by [DiaMedica Therapeutics Inc, DMAC]. During the last 5-days, its volume was better the volume of 0.23 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 29.35% While, its Average True Range was 26.25.
Raw Stochastic average of DiaMedica Therapeutics Inc (DMAC) in the period of the previous 100 days is set at 48.44%, which indicates a major rise in contrast to 8.33% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.40 that was higher than 0.37 volatility it exhibited in the past 100-days period.
